Skip to main content
. 2018 Jul 1;61(4):525–529. doi: 10.3340/jkns.2018.0002

Table 2.

Summary of previous studies of FSRS for brain metastases

No. of reference No. of patients Mean age (years) No. of tumor Location of tumor Treatment modality Median tumor volume (mL) Dose (Gy)/fraction Median OS (months) Local control rate (%)
6 51 55 72 Stem, elquant area Primary 13.0 30–35/5 11 76 (at 1 year)
9 37 60 38 All Primary 17.6 30–41/3–5 10 87 (at 1 year)
19 135 61 171 All Primary 16.4 27–36/3 11 88 (at 1 year)
22 21 59 27 All Primary 5.4 20–40/5 10 86.7 (at 1 year)
26 37 <65 (73%) 37 All Resection cavity 28.8 24/3 6 80 (at 6 months)
Present study 23 61 29 All Primary or resection cavity 18.0 24–33/2–3 10 91.7 (at 1 year)

FSRS : fractionated stereotactic radiosurgery, OS : overall survival